| scholarly article | Q13442814 |
| P2093 | author name string | Donguk Lee | |
| Kathleen Boesze-Battaglia | |||
| Chizobam Idahosa | |||
| Hariharan Subramanian | |||
| Hydar Ali | |||
| Kshitij Gupta | |||
| Saptarshi Roy | |||
| Jonathan Korostoff | |||
| Anuradha Dhingra | |||
| P2860 | cites work | Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization | Q24296488 |
| Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions | Q24310253 | ||
| MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion | Q24314831 | ||
| Porphyromonas gingivalis as a potential community activist for disease | Q24616806 | ||
| Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? | Q24655246 | ||
| LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells | Q24675869 | ||
| Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases | Q28079028 | ||
| The chemistry and biology of LL-37 | Q28265694 | ||
| Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway | Q28612022 | ||
| Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response | Q28658053 | ||
| Different activation signals induce distinct mast cell degranulation strategies | Q30827625 | ||
| Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide | Q33251439 | ||
| Mast cells as sentinels of innate immunity | Q33536530 | ||
| Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses. | Q33789766 | ||
| Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation | Q33882825 | ||
| Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts | Q34648053 | ||
| Microbial shift and periodontitis | Q34680857 | ||
| Correlation of mast cells in periodontal diseases | Q34697727 | ||
| PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells | Q35008885 | ||
| Mast cell secretory granules: armed for battle | Q35182662 | ||
| G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2. | Q35202333 | ||
| Overexpressions of hBD-2, hBD-3, and hCAP18/LL-37 in Gingiva of Diabetics with Periodontitis | Q35669150 | ||
| Mast cells--a role in periodontal diseases? | Q35772663 | ||
| Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis | Q36147919 | ||
| Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. | Q36376749 | ||
| Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria | Q36932099 | ||
| β-Defensins activate human mast cells via Mas-related gene X2. | Q36951709 | ||
| Defensin participation in innate and adaptive immunity | Q36990379 | ||
| Antimicrobial peptides in periodontal innate defense | Q36991831 | ||
| Heterogeneous Porphyromonas gingivalis LPS modulates immuno-inflammatory response, antioxidant defense and cytoskeletal dynamics in human gingival fibroblasts | Q37188987 | ||
| Breaking bad: manipulation of the host response by Porphyromonas gingivalis. | Q37586359 | ||
| Periodontitis: a polymicrobial disruption of host homeostasis | Q37761827 | ||
| Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis | Q37780267 | ||
| An update on innate defense molecules of human gingiva | Q37866354 | ||
| TLR signaling in mast cells: common and unique features | Q38025397 | ||
| Defensins and LL-37: a review of function in the gingival epithelium | Q38127778 | ||
| Immune modulation by multifaceted cationic host defense (antimicrobial) peptides | Q38162670 | ||
| Host defense peptides: front-line immunomodulators | Q38239034 | ||
| Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties | Q38285790 | ||
| Mast cells in human and experimental cardiometabolic diseases | Q38563903 | ||
| Variants of Porphyromonas gingivalis lipopolysaccharide alter lipidation of autophagic protein, microtubule-associated protein 1 light chain 3, LC3. | Q38733696 | ||
| Modulation of host defense peptide-mediated human mast cell activation by LPS. | Q38824103 | ||
| Redefinition of the human mast cell transcriptome by deep-CAGE sequencing | Q38967503 | ||
| Quantification of tryptase-TIM-3 double-positive mast cells in human chronic periodontitis | Q39084437 | ||
| Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. | Q39570767 | ||
| Mast Cells Contribute to Porphyromonas gingivalis-induced Bone Loss | Q39954935 | ||
| Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. | Q40014914 | ||
| Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site | Q40184272 | ||
| Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. | Q40479365 | ||
| Quantification of mast cells in different stages of periodontal disease | Q40609287 | ||
| Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. | Q40640528 | ||
| Correlation of mast cells in different stages of human periodontal diseases: Pilot study | Q41188383 | ||
| Lipopolysaccharide from Porphyromonas gingivalis stimulates rat mast cells to cysteinyl leukotriene generation and upregulates Toll-like receptor -2 and -4 expression. | Q42860261 | ||
| Microbial hijacking of complement-toll-like receptor crosstalk | Q42911622 | ||
| A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis | Q43969583 | ||
| Noncanonical inflammasome activation by intracellular LPS independent of TLR4. | Q44450840 | ||
| Mast cells in human periodontal disease. | Q44865940 | ||
| Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies | Q45024776 | ||
| Quantification of mast cells in different stages of human periodontal disease. | Q46572182 | ||
| Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis | Q47681957 | ||
| Mast cell degranulation in human periodontitis | Q50248557 | ||
| Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. | Q50335870 | ||
| Identification of periodontitis associated changes in the proteome of whole human saliva by mass spectrometric analysis. | Q50888484 | ||
| beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. | Q51972625 | ||
| Mast cells are increased in the media of coronary lesions in patients with myocardial infarction and may favor atherosclerotic plaque instability. | Q53082992 | ||
| Influence of periodontal status and periodontopathogens on levels of oral human β-defensin-2 in saliva. | Q54282627 | ||
| Salivary levels of antibacterial peptide (LL-37/hCAP-18) and cotinine in patients with chronic periodontitis. | Q54347097 | ||
| Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. | Q55036173 | ||
| Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability | Q57273088 | ||
| Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice | Q63258329 | ||
| Mast cells in innate immunity | Q63353738 | ||
| Crucial role for autophagy in degranulation of mast cells | Q63609781 | ||
| Mast cells in periodontal disease | Q67697510 | ||
| Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function | Q68155580 | ||
| Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors | Q80273382 | ||
| Mast cells initiate early anti-Listeria host defences | Q80832242 | ||
| Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria | Q88130953 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| Porphyromonas gingivalis | Q3214147 | ||
| mast cell | Q191989 | ||
| lipopolysaccharide | Q421804 | ||
| P577 | publication date | 2017-09-20 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide | |
| P478 | volume | 85 |
| Q93060094 | IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming |
| Q90079376 | Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions |
| Q88792599 | Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and Icatibant |
| Q64953708 | Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs. |
| Q64251899 | Superantigenic Activation of Human Cardiac Mast Cells |
| Q47151536 | Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1. |
Search more.